(Q46791715)

English

Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

common variable immunodeficiency

1 reference

based on heuristic

inferred from title

author name string

Shoban Davé

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

John Hagan

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

99

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

567-570

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

Tackling the heterogeneity of CVID.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

IGIV: contents, properties, and methods of industrial production--evolving closer to a more physiologic product

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immunoglobulin: striving for appropriate use.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks associated with the use of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous immunoglobulin: adverse effects and safe administration

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of intravenous immunoglobulin G (IVIG).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intravenous immunoglobulin therapy on plasma complement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose intravenous immunoglobulin treatment activates complement in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960388-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)60388-2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18219840

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46791715&oldid=2132245152"